[1]朱青 李明 王佳音 吴太鼎 陈宗海 朱垚 陈龙菊.姜黄素经SLC7A11调控骨肉瘤细胞铁死亡机制初探[J].陕西中医药大学学报,2024,(02):017-21.[doi:10.13424/j.cnki.jsctcm.2024.02.004]
 ZHU QingLI Ming WANG JiayinWUTaidingCHEN Zonghai ZHU YaoCHEN Longju.Preliminary Study on the Mechanism of Curcumin Regulating Iron Death in Osteosarcoma Cells through SLC7A11[J].Journal of Shaanxi University of Traditional Chinese Medicine,2024,(02):017-21.[doi:10.13424/j.cnki.jsctcm.2024.02.004]
点击复制

姜黄素经SLC7A11调控骨肉瘤细胞铁死亡机制初探()
分享到:

《陕西中医药大学学报》[ISSN:2096-1340/CN:61-1501/R]

卷:
期数:
2024年02期
页码:
017-21
栏目:
出版日期:
2024-03-20

文章信息/Info

Title:
Preliminary Study on the Mechanism of Curcumin Regulating Iron Death in Osteosarcoma Cells through SLC7A11
文章编号:
2096-1340(2024)02-0017-05
作者:
朱青1 李明1 王佳音1 吴太鼎1 陈宗海1 朱垚2 陈龙菊1
1.湖北民族大学医学部,湖北 恩施 445000;
2.南京中医药大学,江苏 南京 210029
Author(s):
ZHU Qing1LI Ming1 WANG Jiayin1WUTaiding1CHEN Zonghai1 ZHU Yao1CHEN Longju1
1.Medical Department of Hubei University for Nationalities,Hubei Enshi 445000,China;
2.Nanjing University of Chinese Medicine,Nanjing 210029,China
关键词:
关键词:姜黄素溶质载体家族7成员11骨肉瘤铁死亡
Keywords:
Key words: Curcumin7 members of the solute carrier family 11OsteosarcomaFerroptosis
分类号:
B21,R221
DOI:
10.13424/j.cnki.jsctcm.2024.02.004
文献标志码:
A
摘要:
摘 要:目的 初步探讨姜黄素(curcumin,Cur)经SLC7A11调探对骨肉瘤U-2 OS细胞铁死亡的影响。方法 CCK-8法检测0、5、10、20、40、80 μmol·L-1的Cur对U-2 OS细胞抑制的影响,同时在倒置显微镜下观察细胞形态学的变化。其次,将体外培养U-2 OS细胞随机分为Con组(0 μmol·L-1)、Fer-1组(4 μmol·L-1)、Cur组(40 μmol·L-1)、Cur+Fer-1组(40 μmol·L-1+4 μmol·L-1)用Western blot法检测SLC7A11的表达。结果 Cur在浓度为10~80 μmol·L-1时均对U-2 OS细胞显著性抑制。进一步研究表明,Cur可以显著诱导U-2 OS细胞铁死亡,下调SLC7A11的表达。结论 Cur可以诱导U-2 OS细胞铁死亡,其机制可能是通过下调SLC7A11实现铁死亡。
Abstract:
Abstract: Objective To investigate the effect of curcumin (Cur) on ferroptosis in osteosarcoma U-2 OS cells based on SLC7A11.Methods The CCK-8 method was used to detect the effect of Cur at 0,5,10,20,40,and 80 μmol·L-1 on the inhibition of U2-OS cells,and the morphological changes of cells were observed under an inverted microscope.Secondly,U-2 OS cells cultured in vitro were randomly divided into Con group (0 μmol·L-1),Fer-1 group (4 μmol·L-1),Cur group (40 μmol·L-1),and Cur+Fer-1 group (40 μmol·L-1+4 μmol·L-1),and the expression of SLC7A11 was detected using Western blot.Results Cur significantly inhibited U-2 OS cells at concentrations of 10-80 μmol·L-1.Further research has shown that Cur can significantly induce ferroptosis in U-2 OS cells and downregulate the expression of SLC7A11.Conclusion Cur can induce ferroptosis in U-2 OS cells,and its mechanism may be achieved by downregulating SLC7A11 to achieve ferroptosis.

参考文献/References:

[1]Funovics PT.Primary malignant bone tumors[J].Orthopadie (Heidelb),2023,52(6):509-522.
[2]Keil L.Bone Tumors: Primary Bone Cancers[J].FP Essent,2020,493:22-26.
[3]Liu D,Peng Y,Li X,et al.Comprehensive landscape of TGFβ-related signature in osteosarcoma for predicting prognosis,immune characteristics,and therapeutic response[J].J Bone Oncol,2023,40:100484.
[4]Zhao X,Wu QR,Gong XQ,et al.Osteosarcoma: a review of current and future therapeutic approaches[J].Biomed Eng Online,2021,20(1):24.
[5]Meltzer PS,Helman LJ.New Horizons in the Treatment of Osteosarcoma[J].N Engl J Med,2021,385(22):2066-2076.
[6]Chen CL,Xie Lu,Ren TT,et al.Immunotherapy for osteosarcoma: Fundamental mechanism,rationale,and recent breakthroughs[J].Cancer Lett,2021,500:1-10.
[7]林海英杰.姜黄素类似物EF24通过HMOX-1介导骨肉瘤细胞铁死亡的机制研究[D].广州:南方医科大学,2020.
[8]Soula M,Weber RA,Zilka O,et al.Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers[J].Nat Chem Biol,2020,16(12):1351-1360.
[9]Guo JP,Xu BF,Han Qi,et al.Ferroptosis: A novel anti-tumor action for cisplatin[J].Cancer Res Treat,2018,50(2):445-460.
[10]国家药典委员会.中华人民共和国药典(一部?)[S].2020版.北京:中国医药科技出版社,2020:2.
[11]韦星船.姜黄素类似物的合成及抗肿瘤活性研究[D].广州:广东工业大学,2011.
[12]Cao XL,Li Y,Wang YB,et al.Curcumin suppresses tumorigenesis by ferroptosis in breast cancer[J].PLoS One,2022,17(1):e0261370.
[13]Chen HJ,Li ZF,Xu JC,et al.Curcumin induces ferroptosis in follicular thyroid cancer by upregulating ho-1 expression[J].Oxid Med Cell Longev,2023:6896790.?
[14]Tang X,Ding H,Liang ML,et al.Curcumin induces ferroptosis in non-small-cell lung cancer via activating autophagy[J].Thorac Cancer,2021,12(8):1219-1230.
[15]孙静,孙艳涛,张振秋.中药莪术中姜黄素、去甲氧基姜黄素、双去甲氧基姜黄素的含量测定[J].中国医院药学杂志,2010,30(8):714-716.
[16]Huang ZH,Jin GY.Licochalcone B induced apoptosis and autophagy in osteosarcoma tumo cells via the inactivation of PI3K/AKT/mTOR pathway[J].Biol Pharm Bull,2022,45(6):730-737.
[17]Zheng YD,He Z,Su ZC,et al.Bufalin induces apoptosis and autophagy via the Ca2+/CaMKKβ/AMPK/Beclin1 signaling pathway in osteosarcoma cells[J].Cell Biology international,2023,47(8):1344-1353.
[18]Wen RJ,Dong X,Zhuang HW,et al.Baicalin induces ferroptosis in osteosarcomas through a novel Nrf2/xCT/GPX4 regulatory axis[J].Phytomedicine,2023,116:154881.
[19]Luo ZP,Li DW,Luo XB,et al.Curcumin ma serve an anticancer role in human osteosarcoma cell line U-2 OS by targeting?ITPR1[J].Oncol Lett,2018,15(4):5593-5601.
[20]Wang XB,Chen YQ,Wang XD,et al.Stem cell factor SOX2 confers ferroptosis resistance in lung cancer via upregulation of SLC7A11[J].Cancer Res,2021,81(20):5217-5229.
[21]Zhang WJ,Sun Y,Bai L,et al.RBMS1 regulates lung cancer ferroptosis through translational control of SLC7A11[J].J Clin Invest,2021,131(22):e152067.
[22]Chen QP,Zheng W,Guan J,et al.SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma[J].Cell Death Differ,2023,30(1):137-151.
[23]Hong T,Lei G,Chen X,et al.PARP?inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer[J].Redox Biol,2021:101928.
[24]Shen LL,Zhang JF,Zheng ZT,et al.PHGDH inhibits ferroptosis and promotes malignant progression by upregulating SLC7A11 in bladder cancer[J].Int J?Biol Sci,2022,18(14):5459-5474.
[25]Cheng X,Wang YD,Liu LC,et al.SLC7A11,a potential therapeutic target through induced ferroptosis in colon adenocarcinoma[J].Front Mol? Biosci,2022:889688.
[26]Yang JJ,Zhou YL,Xie SD,et al.Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer[J].J Exp Clin Cancer Res,2021,40(1):206.

相似文献/References:

[1]魏蕾焦韵苹李娜 李阳.温度响应性水凝胶的制备及其对姜黄素的控制释放研究[J].陕西中医药大学学报,2022,(01):072.[doi:10.13424/j.cnki.jsctcm.2022.01.016]
 WEI Lei JIAO Yunping LI Na LI Yang.Preparation of Temperature Responsive Hydrogel and Its Controlled Release of Curcumin[J].Journal of Shaanxi University of Traditional Chinese Medicine,2022,(02):072.[doi:10.13424/j.cnki.jsctcm.2022.01.016]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金项目(81260192)
更新日期/Last Update: 2024-03-29